🔗 Permalink

Inventor profile of:

René Eifler

City:

Koblenz

Country:

Germany

Published Applications:

Last publication date:

2024-08-29

Top Assignees for applications by René Eifler

The entities that hold a legal rights for patent applications filed by inventor Eifler René:

LTS LOHMANN THERAPIE-SYSTEME AG 16 Andernach, Germany
LTS Lohmann Therapie-Systeme AG 1 Andermach, Germany
Gruenenthal GmbH 1 Aachen, Germany

Recent patent applications by Eifler René

René Eifler from Koblenz, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-08-29

US20240285546A1

Human necessities

TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING AGOMELATINE

#2 | 2024-07-04

US20240216299A1

Human necessities

TRANSMUCOSAL THERAPEUTIC SYSTEM CONTAINING AGOMELATINE

#3 | 2023-12-14

US20230399335A1

Chemistry; metallurgy

PROCESS FOR THE PREPARATION OF ASENAPINE IN THE FORM OF ITS FREE BASE

#4 | 2023-11-30

US20230381116A1

Human necessities

CONTROLLING WATER RELEASE FROM A DIMENSIONALLY STABLE AQUEOUS COMPOSITION

#5 | 2022-12-22

US20220401389A1

Human necessities

TRANSMUCOSAL THERAPEUTIC SYSTEM CONTAINING AGOMELATINE

#6 | 2022-10-13

US20220323370A1

Human necessities

TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING ASENAPINE AND POLYSILOXANE OR POLYISOBUTYLENE

#7 | 2021-10-28

US20210330601A1

Human necessities

Transdermal therapeutic system containing asenapine

#8 | 2021-09-16

US20210287764A1

Physics

SYSTEM FOR DETERMINING A SUITABILITY OF AN ACTIVE INGREDIENT TO BE APPLIED TRANSDERMALLY OR TRANSMUCOSALLY AND CORRESPONDING METHOD

#9 | 2021-08-19

US20210251915A1

Human necessities

Transdermal therapeutic system containing asenapine

#10 | 2021-08-19

US20210251914A1

Human necessities

TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING ASENAPINE

#11 | 2020-06-18

US20200188317A1

Human necessities

Transdermal therapeutic system containing asenapine

#12 | 2020-06-11

US20200179298A1

Human necessities

Transdermal therapeutic system containing asenapine and silicone acrylic hybrid polymer

#13 | 2020-03-19

US20200085759A1

Human necessities

Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene

#14 | 2019-12-05

US20190365662A1

Human necessities

Controlling water release from a dimensionally stable aqueous composition

#15 | 2019-11-07

US20190336454A1

Human necessities

Transdermal therapeutic system containing asenapine

#16 | 2019-10-03

US20190298662A1

Human necessities

TRANSDERMAL ADMINISTRATION OF MEMANTINE

#17 | 2018-07-12

US20180193283A1

Human necessities

TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING ASENAPINE

#18 | 2017-02-16

US20170046504A1

Physics

SYSTEM FOR DETERMINING A SUITABILITY OF AN ACTIVE INGREDIENT TO BE APPLIED TRANSDERMALLY OR TRANSMUCOSALLY AND CORRESPONDING METHOD

#19 | 2015-08-20

US20150231154A1

Human necessities

Transdermal therapeutic system comprising norelgestromin for contraception and hormone replacement

#20 | 2012-03-15

US20120065599A1

Human necessities

Transdermal therapeutic system having controlled active substance flow comprising a basic reacting oxide

#21 | 2011-12-22

US20110313372A1

Human necessities

Transdermal administration of memantine

#22 | 2010-06-17

US20100150993A1

Human necessities

Transdermal therapeutic system comprising norelestromin for contraception and hormone replacement

InventorID:

1260058 ⎘